Can the UK ‘Netflix’ Payment Model Boost the Antibacterial Pipeline?

Colm Leonard (), Nick Crabb, David Glover, Sophie Cooper, Jacoline Bouvy, Milena Wobbe and Mark Perkins
Additional contact information
Colm Leonard: National Institute for Health and Care Excellence
Nick Crabb: National Institute for Health and Care Excellence
David Glover: NHS England and NHS Improvement
Sophie Cooper: National Institute for Health and Care Excellence
Jacoline Bouvy: National Institute for Health and Care Excellence
Milena Wobbe: National Institute for Health and Care Excellence
Mark Perkins: NHS England and NHS Improvement

Applied Health Economics and Health Policy, 2023, vol. 21, issue 3, No 2, 365-372

Abstract: Abstract The silent pandemic of antimicrobial resistance (AMR) is a global issue needing prompt attention. A comprehensive one-health approach across human and animal health, agriculture and the environment is needed to solve this, addressing overuse of antibacterials, and of course, optimising measures for preventing and controlling infection. We also need a robust pipeline of new antibacterials. However, the current pipeline is inadequate and several companies with new antibacterials have gone bankrupt due to low sales, leading to a ‘broken market’. To address this, the UK has completed a project using novel approaches to value assessment and reimbursement for two antibacterials. The new funding arrangements for these products commenced on 1st July 2022, delinking reimbursement from volume of sales; a so-called ‘pull incentive’, with payments based on the added value to the whole-health and social-care system, not just to individual patients. This article describes how the project was devised, developed, and progressed. The learning from this work might help other countries to adopt or adapt the approach to fit with their national systems, and collectively achieve a global incentive to reinvigorate the antibacterial pipeline.

Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40258-022-00786-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:21:y:2023:i:3:d:10.1007_s40258-022-00786-1

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/s40258-022-00786-1

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().